Industry oestrogen study "fundamentally flawed"

An industry-funded study claimed to have demonstrated the safety of an important ingredient of plastics and resins is "fundamentally flawed", according to academic scientists. Instead of allaying fears over the oestrogenic properties of bisphenol A, the study appears to be a major embarrassment for the chemical industry.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Take a 30-day trial

  • Join ENDS Report now and pay nothing for your first 30-days.



Prices on request

  • Full access to for 12 months
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits

Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access